** Shares in Fagron FAGRO.BR rise 7%, pares gains after
rising as much as 8%, after Belgium's healthcare firm posted a
15% growth in Q1 revenue, to 209 million euros ($224.36 million)
** KBC Securities flags that growth was mainly driven by
continued strong performance in North America and robustness in
EMEA
** ING says that Fagron's solid numbers in these two regions
are supported by solid development in Compounding services, up
37.4% YoY in the US and 17% in EMEA
** "Fagron again overdelivered on our and consensus
expectations and this should further increase investor’s
confidence in this attractive growth case", says Degroof
Petercam
** Fagron confirmed its FY 2024 outlook, expecting high
single digit organic sales growth and improvement in
profitability
** Including today's rise the stock has gained 10.3% YTD
($1 = 0.9315 euros)
(Reporting by Alban Kacher)
((alban.kacher@thomsonreuters.com))